Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis

Viral Infections, Non-HIV

What will it take to end human suffering from measles?

Read the related article: Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis

Viral Infections, Non-HIV

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules

Lancet Glob Health.

Clark A, Tate J, Parashar U, Jit M, Hasso-Agopsowicz M, Henschke N, Lopman B, Van Zandvoort K, Pecenka C, Fine P, Sanderson C

doi: 10.1016/S2214-109X(19)30412-7.

HIV / AIDSViral Infections, Non-HIV

Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis

J Infect Dis.

Martin NK, Jansen K, An der Heiden M, Boesecke C, Boyd A, Schewe K, Baumgarten A, Lutz T, Christensen S, Thielen A, Mauss S, Rockstroh JK, Skaathun B, Ingiliz P

doi: 10.1093/infdis/jiz367.

Viral Infections, Non-HIV

The Consensus Hepatitis C Cascade of Care: standardized reporting to monitor progress toward elimination

Clin Infect Dis.

Safreed-Harmon K, Blach S, Aleman S, Boe Kielland K, Bollerup S, Cooke G, Dalgard O, Dillon JF, Dore GJ, Duberg AS, Grebely J, Midgard H, Porter K, Razavi H, Tyndall M, Weis N, Lazarus JV

doi: 10.1093/cid/ciz714.

Viral Infections, Non-HIV

Approaching measles elimination in Switzerland: changing epidemiology 2007-2018

Swiss Med Wkly.

Richard JL, Mäusezahl M, Basler S, Eckert N

doi: 10.4414/smw.

Viral Infections, Non-HIV

Estimating the effect of measles vaccination on child growth using 191 DHS from 65 low- and middle-income countries

Vaccine.

Bogler L, Jantos N, Bärnighausen T, Vollmer S

doi: 10.1016/j.vaccine.

Complex Regional Pain Syndrome (CRPS)

Elimination of Viral Hepatitis in Low and Middle-Income Countries: Epidemiological Research Gaps

Curr Epidemiol Rep

Jaquet A, Muula G, Ekouevi DK, Wandeler G

doi: 10.1007/s40471-021-00273-6

Viral Infections, Non-HIV

Maternal immunization: A call to accelerate progress

Vaccine.

Bardají A, MacDonald NE, Omer SB, Aguado T

doi: 10.1016/j.vaccine.2019.04.031.

Viral Infections, Non-HIV

C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study

BMC Med.

Vuong NL, Le Duyen HT, Lam PK, Tam DTH, Vinh Chau NV, Van Kinh N, Chanpheaktra N, Lum LCS, Pleités E, Jones NK, Simmons CP, Rosenberger K, Jaenisch T, Halleux C, Olliaro PL, Wills B, Yacoub S

doi: 10.1186/s12916-020-1496-1.

Related content

What will it take to end human suffering from measles?

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules

Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis

The Consensus Hepatitis C Cascade of Care: standardized reporting to monitor progress toward elimination

Approaching measles elimination in Switzerland: changing epidemiology 2007-2018

Estimating the effect of measles vaccination on child growth using 191 DHS from 65 low- and middle-income countries

Elimination of Viral Hepatitis in Low and Middle-Income Countries: Epidemiological Research Gaps

Maternal immunization: A call to accelerate progress

C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study